Previous studies of TGP in the treatment of RA, which were carried out over short term periods, showed that TGP can inhibit the production of VEGF and ameliorate the abnormal proliferation of synoviocytes in CIA rats (Zhu et al., 2005; Deng et al., 2010; Zhang and Dai, 2012); TGP was also shown to reduce the differentiation of Th1 and Th17 cells in CIA mice (Lin et al., 2012). The gene discussed is VEGFA; the disease is rheumatoid arthritis.